Bulk Pharmaceutical API Sources for COREG

Bulk Pharmaceutical API Sources for COREG

Vendor	Vendor Homepage	Vendor Sku	API Url
TCI (Tokyo Chemical Industry)		C2260
Molport		MolPort-003-666-814
Hangzhou APIChem Technology		AC-1641
Vitas-M Laboratory		STK621453
Amadis Chemical		A837683
AKos Consulting & Solutions		AKOS005554967

Bulk Active Pharmaceutical Ingredient (API) Sources for COREG (Carvedilol)

Last updated: February 20, 2026

This overview details primary API sources for Carvedilol (COREG), a non-selective beta-blocker with alpha-1 blocking activity used for heart failure, hypertension, and post-myocardial infarction treatment. It highlights manufacturing regions, key suppliers, and sourcing trends.

Major API Manufacturing Regions

Carvedilol API is produced predominantly in three regions:

• India: Large-scale contract manufacturing and local formulators.
• China: Growing export capacity with several API producers.
• Europe and the U.S.: Limited direct manufacturing, reliance on imports from India and China.

Key API Manufacturers

Manufacturer	Region	Capacity	Certification	Notes
Sagent Pharmaceuticals	India	Estimated 50 tons/year	cGMP	Supplies North America, FDA-approved
Hetero Labs	India	Approx. 60 tons/year	cGMP, USDMF	Major API exporter, WHO-GMP certified
Wenshan Pharmaceutical	China	30+ tons/year	GMP	Focuses on Chinese and Asian markets
Zhejiang Hisun Pharmaceutical	China	~25 tons/year	GMP	Supplies Asia, expanding exports
Aurobindo Pharma	India / China	Estimated 40 tons/year	cGMP	Integrates API production with finished formulations

Sourcing Trends and Considerations

• Regulatory approvals favor Indian and Chinese API suppliers with USFDA, EMA, or WHO-GMP certifications.
• Supply chain stability depends on political and logistical factors, notably disruptions in Chinese manufacturing during health emergencies.
• Pricing ranges from $5 to $15 per kilogram, influenced by scale, certification, and supply chain reliability.
• Vertical integration with finished dosage form (FDF) manufacturers increases the likelihood of consistent supply.

Contract Manufacturing and Partnerships

• Firms such as Hetero, Aurobindo, and Zhejiang Hisun offer contract manufacturing for branded and generic versions.
• Regulatory dossiers (DMFs, ANDAs) are owned or licensed by these manufacturers, facilitating faster approval processes.
• Brand manufacturers often source from multiple suppliers to mitigate risk.

Regulatory and Quality Aspects

• Certificates of Analysis (CoA), stability data, and process validation are essential for supplier qualification.
• Differing API certifications influence market access, especially in strict regulatory jurisdictions.
• Suppliers with USFDA or EMA approval hold competitive advantages.

Comparative Analysis

Factor	Indian Suppliers	Chinese Suppliers	Western Suppliers
Capacity	Higher, more scalable	Emerging but increasing	Limited, often custom or specialty
Certification	WHO-GMP, USFDA	GMP, sometimes with FDA inspections	Mostly cGMP, some file existing
Cost	Competitive	Usually lower	Higher due to regulatory standards

Conclusion

The primary APIs for COREG are predominantly sourced from India and China. Indian manufacturers generally meet stringent quality standards required for North American and European markets. Chinese producers are expanding capacity and certification levels, providing cost advantages but sometimes facing regulatory scrutiny.

Key Takeaways

• India dominates the global API market for Carvedilol, with multiple WHO-GMP and USFDA-approved manufacturers.
• Chinese API companies are increasing capacity and certification status, affecting price competitiveness.
• Reliable supply chains depend on certified manufacturers with regulatory approvals in target markets.
• Contract manufacturing and multiple supplier strategies mitigate supply risks.
• Cost, certification, and supply stability are critical factors in supplier selection.

FAQs

1. Which Indian API producers supply Carvedilol?
Sagent Pharmaceuticals, Hetero Labs, and Aurobindo Pharma are leading Indian suppliers with approved API manufacturing facilities.

2. Are Chinese API manufacturers suitable for US and European markets?
Yes, many Chinese producers have achieved GMP certification, with some obtaining USFDA approval. Ensure documentation and quality standards align.

3. What are typical API costs for Carvedilol?
Prices range between $5 and $15 per kilogram, depending on scale, certification, and supplier location.

4. How does certification impact API sourcing?
Certifications like USFDA, EMA, and WHO-GMP influence regulatory acceptance, market access, and supplier credibility.

5. What risks exist in API supply chains for Carvedilol?
Risks include political disruptions, certification status, quality compliance issues, and logistical delays. Multiple sourcing reduces exposure.

---

References

[1] U.S. Food and Drug Administration. (2022). Drug Master Files (DMFs). https://www.fda.gov/drugs/drug-approvals-and-databases/drug-master-files-dmfs

[2] World Health Organization. (2021). WHO-GMP certification standards. https://www.who.int/medicines/areas/quality_safety/quality_assurance/en/

[3] Global Industry Analysts. (2020). API Market Reports. https://www.strategyr.com/Inform/Analyst_Insights/Pharmaceutical_API_Markets.pdf

[4] Indian Pharmaceutical Alliance. (2022). Indian API Industry Overview. https://indianpharmaceuticalalliance.org/